Skip to main content

Table 3 Odds ratio and 95% CI of each component of MetS at 3-year follow-up according to baseline hemoglobin quartiles in women

From: Hemoglobin concentration is associated with the incidence of metabolic syndrome

MetS

Q1 (< 130 g/L)

Q2 (130-136g/L)

Q3 (137-142g/L)

Q4 (≥143 g/L)

n = 716

n = 654

n = 703

n = 719

Incidence, n (%)

242 (33.8)

218 (33.3)

281 (40.0)

304 (42.3)

Model 1

1 (Ref)

0.98 (0.78–1.23)

1.30 (1.05–1.62) *

1.44 (1.15–1.78) *

Model 2

1 (Ref)

0.93 (0.74–1.18)

1.32 (1.05–1.66) *

1.47 (1.17–1.84) *

Model 3†

1 (Ref)

0.88 (0.67–1.18)

1.24 (0.95–1.62)

1.09 (0.83–1.44)

WC

Q1 (< 131 g/L)

Q2 (131-136g/L)

Q3 (137-142g/L)

Q4 (≥143 g/L)

n = 499

n = 456

n = 453

n = 483

Incidence, n (%)

238 (47.7)

203 (44.5)

242 (53.4)

246 (50.9)

Model 1

1 (Ref)

0.88 (0.68–1.14)

1.26 (0.98–1.62)

1.14 (0.89–1.46)

Model 2

1 (Ref)

0.90 (0.67–1.17)

1.24 (0.95–1.61)

1.13 (0.87–1.48)

Model 3‡

1 (Ref)

0.92 (0.70–1.22)

1.17 (0.88–1.56)

1.02 (0.76–1.37)

BP

Q1 (< 130 g/L)

Q2 (130-136g/L)

Q3 (137-142g/L)

Q4 (≥143 g/L)

n = 509

n = 572

n = 522

n = 512

Incidence, n (%)

216 (42.4)

224 (39.2)

247 (47.3)

224 (43.8)

Model 1

1 (Ref)

0.87 (0.69–1.11)

1.22 (0.95–1.56)

1.06 (0.83–1.35)

Model 2

1 (Ref)

0.81 (0.63–1.05)

1.19 (0.92–1.54)

1.00 (0.77–1.30)

Model 3§

1 (Ref)

0.81 (0.61–1.06)

1.20 (0.91–1.59)

0.95 (0.71–1.27)

TGs

Q1 (< 131 g/L)

Q2 (131-137g/L)

Q3 (138-143g/L)

Q4 (≥144 g/L)

n = 835

n = 946

n = 815

n = 847

Incidence, n (%)

142 (17.0)

201 (21.2)

193 (23.7)

205 (24.2)

Model 1

1 (Ref)

1.32 (1.04–1.67) *

1.51 (1.19–1.93) *

1.56 (1.23–1.98) *

Model 2

1 (Ref)

1.23 (0.96–1.58)

1.49 (1.16–1.91) *

1.47 (1.15–1.89) *

Model 3¶

1 (Ref)

1.11 (0.84–1.45)

1.36 (1.02–1.80) *

1.05 (0.79–1.41)

HDL-c

Q1 (< 132 g/L)

Q2 (132-138g/L)

Q3 (139-144g/L)

Q4 (≥145 g/L)

n = 566

n = 612

n = 537

n = 556

Incidence, n (%)

114 (20.1)

141 (23)

132 (24.6)

147 (26.4)

Model 1

1 (Ref)

1.19 (0.90–1.57)

1.29 (0.97–1.72)

1.43 (1.08–1.88) *

Model 2

1 (Ref)

1.17 (0.88–1.56)

1.27 (0.95–1.70)

1.46 (1.09–1.93) *

Model 3††

1 (Ref)

1.06 (0.78–1.43)

1.10 (0.80–1.50)

1.14 (0.83–1.57)

FBG

Q1 (< 131 g/L)

Q2 (131-136g/L)

Q3 (137-142g/L)

Q4 (≥143 g/L)

n = 455

n = 434

n = 449

n = 437

Incidence, n (%)

118 (25.9)

106 (24.4)

117 (26.1)

118 (27.0)

Model 1

1 (Ref)

0.92 (0.68–1.25)

1.01 (0.75–1.36)

1.06 (0.79–1.42)

Model 2

1 (Ref)

0.91 (0.66–1.25)

1.06 (0.78–1.44)

1.06 (0.78–1.46)

Model 3‡‡

1 (Ref)

0.95 (0.66–1.35)

1.00 (0.69–1.43)

0.94 (0.64–1.38)

  1. Abbreviations: CI, confidential interval; WC, waist circumference; DBP, diastolic blood pressure; SBP, systolic blood pressure; FPG, fasting plasma glucose; HDL-c, high-density lipoprotein cholesterol; TGs, triglycerides; eGFR, estimated glomerular filtration rate; the use of bold emphasis and * are to mark the statistically significant indicators
  2. Model 1 is unadjusted;
  3. Model 2 is adjusted for age, education, smoking and drinking;
  4. Model 3† is adjusted for age, education, smoking, drinking, WC, SBP, DBP, FPG, HDL-c, TGs, uric acid, NAFLD and eGFR
  5. Model 3‡ is adjusted for age, education, smoking, drinking, SBP, DBP, FPG, HDL-c, TGs, uric acid, NAFLD and eGFR
  6. Model 3§ is adjusted for age, education, smoking, drinking, WC, FPG, HDL-c, TGs, uric acid, NAFLD and eGFR
  7. Model 3¶ is adjusted for age, education, smoking, drinking, WC, SBP, DBP, FPG, HDL-c, uric acid, NAFLD and eGFR
  8. Model 3†† is adjusted for age, education, smoking, drinking, WC, SBP, DBP, FPG, TGs, uric acid, NAFLD and eGFR
  9. Model 3‡‡ is adjusted for age, education, smoking, drinking, WC, SBP, DBP, HDL-c, TGs, uric acid, NAFLD and eGFR